BREAKING NEWS!: FDA Approves Apalutamide (Erleada) for the treatment of metastatic hormone-sensitive prostate cancer. Read More.
Go here to learn more or to get a mailed copy.
Home » Archives for April 2019
Prioritize telling your children Many people face understandable reluctance when deciding whether they should tell their children about their cancer diagnosis. Are they too young? Is it too much for...Read More
The feeling of helplessness brought upon a patient and those who love them is perhaps one of the worst parts of a prostate cancer diagnosis. Between the uncertainty of the...Read More
The phrase “cancer does not discriminate” gets thrown around quite a bit. It comes from a good place –– the idea that cancer is everyone’s problem and that whether you...Read More